Travelers is Sunday's stock review because Friday's earnings give us two different scorecards to examine. The reported underwriting result improved, while the underlying combined ratio edged worse. The balance sheet also tells a different story depending on whether unrealized investment marks are included.
The October 16 regular close was $389.54, up 1.47% for the session and 5.64% from the October 9 close. These are completed Friday prices, not a new Sunday quote.
Per-share growth needs the share-count context
For the quarter ended September 30, reported on October 16, Travelers earned $1.917 billion of GAAP net income, versus $1.888 billion a year earlier. Core income, a non-GAAP measure excluding after-tax net realized investment gains and losses, increased from $1.867 billion to $1.947 billion. Core EPS rose from $8.14 to $9.18. Q3 earnings release.
That is approximately 4.28% growth in core income and 12.78% growth in core EPS. Average diluted shares declined from 227.5 million to 210.6 million. Repurchases helped per-share growth; the EPS increase should not be described as the same increase in total profit. During Q3, the company returned $1.769 billion, comprising $1.508 billion of repurchases and $261 million of dividends.
The headline ratio improved; the underlying ratio did not
The combined ratio improved from 87.30% to 86.80%. A ratio below 100% indicates underwriting profit before investment income, using the insurer's reported premium-and-expense basis. But the underlying ratio, which excludes catastrophes and prior-year reserve development, moved from 83.90% to 84.10%. Lower is better for this measure, so that was a modest deterioration.
Favorable prior-year reserve development increased from $22 million to $234 million, while catastrophe losses rose from $402 million to $538 million, both pretax. Reported underwriting income increased from $1.378 billion to $1.432 billion; underlying underwriting income slipped from $1.758 billion to $1.736 billion. These are different scopes, not interchangeable profit figures.
Net written premiums were $11.480 billion, approximately flat as reported. Written premiums are not the same as revenue. The company separately reports growth excluding the sold Canadian business, which changes the comparison's perimeter. A convincing follow-up would show durable underwriting economics alongside premium growth, rather than relying on reserve releases alone.
Two book values, one investment portfolio
From December 31, 2025 to September 30, 2026, GAAP book value per share fell from $151.21 to $141.48. Adjusted book value per share rose from $158.01 to $172.47. The latter excludes net unrealized investment gains and losses; it does not erase them economically or replace the GAAP number. Q3 financial supplement.
The after-tax unrealized investment loss increased from $1.478 billion to $6.352 billion over those balance-sheet dates. At the same time, quarterly pretax net investment income rose from $1.033 billion to $1.098 billion. Earning more investment income and carrying larger unrealized portfolio losses can happen together. Future rates, credit performance and the timing of insurance liabilities still matter; a reversal of the losses is not guaranteed.
At Friday's price, the shares were approximately 2.75 times September GAAP book value or 2.26 times adjusted book value. Those are two disclosed-denominator arithmetic references, not a claim that either is the correct fair-value multiple.
What the chart adds
The completed 20-day SMA was $367.05, 50-day $369.29 and 200-day $324.11. Friday traded as low as $368.63 and as high as $390.91, then closed above all three averages. The large daily range deserves to remain visible; looking only at the close would hide the earnings-session volatility.
The $390.91 Friday intraday high is the immediate upper reference. Beneath the close, Friday's low and the 50-day average form a nearby dated area, followed by the 20-day average. The October 1 intraday low of $353.79 is a farther lower reference. None is a guaranteed floor or target. A daily retest requires the test and a daily close back above the relevant level; a brief visit alone does not establish it.
The business test is whether underlying underwriting holds up while investment income and portfolio marks evolve. The chart test is whether the advance sustains its dated levels. Strong reported earnings and a strong closing recovery deserve examination, without assuming they settle valuation or the next price move.
See TRV Daily Levels, the week's earnings reviews and other stock reviews.
This is market research only, not a recommendation to buy or sell.